CE

Celanese Corporation [CE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CE Stock Summary

Top 10 Correlated ETFs

CE


Top 10 Correlated Stocks

CE


In the News

02:46 27 Sep 2023 CE

The 7 Most Undervalued Warren Buffett Stocks to Buy in September 2023

If you're among the millions of investors concerned about where to put your money to work, undervalued Warren Buffett stocks to buy may be the place to focus on. Specifically, by aligning your portfolio with certain compelling individual holdings of Berkshire Hathaway (NYSE: BRK-B ), you might be able to get a leg up on market vagaries.

01:41 27 Sep 2023 CE

The 3 Most Undervalued Materials Stocks to Buy in September 2023

My mission, should I choose to accept it, is to find the three most undervalued materials stocks to buy in September. Dr. Ed Yardeni and his capable crew at Yardeni Research produce interesting charts weekly about the S&P 500.

07:31 27 Sep 2023 CE

Celanese (CE) Inks Deal With Population Council for VitalDose

The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.

12:47 27 Sep 2023 CE

Celanese (CE) Up 0.8% Since Last Earnings Report: Can It Continue?

Celanese (CE) reported earnings 30 days ago. What's next for the stock?

03:35 27 Sep 2023 CE

Warren Buffett Just Sold These 3 Stocks. You Should Too.

Warren Buffet is arguably the most successful investor of all time. And while he is known as both a value investor and a long-term, buy-and-hold market participant, he's not averse to selling a stock if it runs against him or the reasons why he bought shares in the first place turn out to be incorrect.

11:00 27 Sep 2023 CE

Celanese (CE) Refinances Debt to Extend Maturity & Reduce Costs

Celanese (CE) is refinancing its debt to extend the maturity of its debt and reduce its borrowing costs by 14 basis points.

05:09 27 Sep 2023 CE

Warren Buffett's Berkshire Hathaway bet on 3 homebuilders - and sold and slashed a bunch of stocks last quarter

Warren Buffett's Berkshire Hathaway added a trio of homebuilders to its portfolio last quarter. The investor's company exited three stocks and slashed several of its positions, SEC filings show.

01:40 27 Sep 2023 CE

Celanese (CE) Q2 Earnings and Sales Fall Short of Estimates

Celanese (CE) misses second-quarter earnings and sales estimates due to slow demand recovery and production cuts.

07:39 27 Sep 2023 CE

Celanese (CE) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Celanese (CE) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

06:54 27 Sep 2023 CE

Celanese (CE) Q2 Earnings and Revenues Miss Estimates

Celanese (CE) came out with quarterly earnings of $2.17 per share, missing the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $4.99 per share a year ago.

CE Financial details

Company Rating
Strong Buy
Market Cap
13.49B
Income
1.27B
Revenue
10.3B
Book val./share
51.64
Cash/share
11.9
Dividend
2.8
Dividend %
2.33%
Employees
13.26K
Optionable
No
Shortable
Yes
Earnings
01 Nov 2023
P/E
10.31
Forward P/E
-
PEG
-3.31
P/S
1.27
P/B
2.33
P/C
10.25
P/FCF
12.07
Quick Ratio
0.83
Current Ratio
1.59
Debt / Equity
2.62
LT Debt / Equity
2.35
-
-
EPS (TTM)
11.69
EPS next Y
-
EPS next Q
5.66
EPS this Y
2.88%
EPS next Y
-
EPS next 5Y
74.38%
EPS last 5Y
14.22%
Revenue last 5Y
6.22%
Revenue Q/Q
-2.03%
EPS Q/Q
140.48%
-
-
-
-
SMA20
3.31%
SMA50
3.31%
SMA100
21.36%
Inst Own
99.38%
Inst Trans
1.05%
ROA
5%
ROE
23%
ROC
0.05%
Gross Margin
22%
Oper. Margin
11%
Profit Margin
12%
Payout
24%
Shs Outstand
108.85M
Shs Float
103.05M
-
-
-
-
Target Price
153.69
52W Range
86.71-131.05
52W High
-6.86%
52W Low
+41.87%
RSI
41
Rel Volume
0.2
Avg Volume
1.26M
Volume
253.6K
Perf Week
-4.9%
Perf Month
4.82%
Perf Quarter
15.07%
Perf Half Y
18.16%
-
-
-
-
Beta
1.30947
-
-
Volatility
2.64%, 3.94%
Prev Close
1.57%
Price
122.01
Change
-0.25%

CE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
53.2850.8248.0176.7689.25
Net income per share
8.996.8816.8516.9917.48
Operating cash flow per share
11.611.747.2215.816.78
Free cash flow per share
9.098.754.1311.611.77
Cash per share
3.54.0612.634.9113.91
Book value per share
22.2220.2329.9337.6652.01
Tangible book value per share
14.9812.220.4621.49-47.44
Share holders equity per share
22.2220.2329.9337.6652.01
Interest debt per share
27.2233.9134.338.28142.54
Market cap
12.08B15.25B15.31B18.69B11.08B
Enterprise value
15.17B18.88B18.28B22.32B24.62B
P/E ratio
10.0117.97.719.895.85
Price to sales ratio
1.692.422.712.191.15
POCF ratio
7.7610.4918.0110.646.09
PFCF ratio
9.914.0731.514.498.68
P/B Ratio
4.056.084.344.461.97
PTB ratio
4.056.084.344.461.97
EV to sales
2.1233.232.612.54
Enterprise value over EBITDA
9.8118.7121.2610.0914.06
EV to operating cash flow
9.7412.9821.5112.7113.53
EV to free cash flow
12.4317.4137.6217.319.29
Earnings yield
0.10.060.130.10.17
Free cash flow yield
0.10.070.030.070.12
Debt to equity
1.181.631.110.992.67
Debt to assets
0.380.430.360.350.57
Net debt to EBITDA
23.593.461.647.73
Current ratio
1.621.581.911.521.63
Interest coverage
10.677.256.0921.383.4
Income quality
1.281.690.430.930.96
Dividend Yield
0.020.020.020.020.03
Payout ratio
0.230.350.150.160.16
Sales general and administrative to revenue
00000
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.150.150.140.180.43
Capex to operating cash flow
-0.22-0.25-0.43-0.27-0.3
Capex to revenue
-0.05-0.06-0.06-0.05-0.06
Capex to depreciation
-0.97-1.04-1.02-1.24-1.14
Stock based compensation to revenue
0.010.0100.010.01
Graham number
67.0355.95106.53120143.01
ROIC
0.170.110.080.190.09
Return on tangible assets
0.150.110.210.190.13
Graham Net
-29.43-37.69-34.85-43.87-144.99
Working capital
1.1B1.01B1.79B1.3B2.54B
Tangible asset value
2.01B1.51B2.41B2.39B-5.14B
Net current asset value
-3.06B-3.81B-3.25B-3.63B-13.56B
Invested capital
1.181.631.110.992.67
Average receivables
1.27B1.25B1.21B1.45B1.86B
Average payables
813M799.5M788.5M978.5M1.34B
Average inventory
973M1.04B1.01B1.25B2.17B
Days sales outstanding
67.2468.4680.1671.2777.51
Days payables outstanding
57.6860.6966.6972.3175.97
Days of inventory on hand
73.6680.7781.8495.01140.53
Receivables turnover
5.435.334.555.124.71
Payables turnover
6.336.015.475.054.8
Inventory turnover
4.964.524.463.842.6
ROE
0.40.340.560.450.34
Capex per share
-2.51-2.99-3.09-4.2-5.01

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
22.9421.2221.6426.2625.67
Net income per share
41.767.070.842.02
Operating cash flow per share
4.574.314.99-0.887
Free cash flow per share
3.423.033.67-2.395.67
Cash per share
7.2989.1913.910.7411.9
Book value per share
45.0245.6551.9552.1151.64
Tangible book value per share
29.5430.94-47.39-46.9-45.75
Share holders equity per share
45.0245.6551.9552.1151.64
Interest debt per share
37.82117.09140.19141.05137.05
Market cap
12.75B9.8B11.09B11.83B12.61B
Enterprise value
16.02B12.67B24.63B25.8B26.06B
P/E ratio
7.3412.823.6232.514.33
Price to sales ratio
5.134.264.724.154.51
POCF ratio
25.7520.9820.5-123.2216.55
PFCF ratio
34.3629.8627.87-45.520.44
P/B Ratio
2.611.981.972.092.24
PTB ratio
2.611.981.972.092.24
EV to sales
6.445.510.499.049.32
Enterprise value over EBITDA
28.327.6253.986.366.14
EV to operating cash flow
32.3627.1245.52-268.7834.2
EV to free cash flow
43.1738.6261.88-99.2442.23
Earnings yield
0.030.020.070.010.02
Free cash flow yield
0.030.030.04-0.020.05
Debt to equity
0.832.532.672.672.62
Debt to assets
0.320.590.570.580.57
Net debt to EBITDA
5.776.25139.5446.7434.13
Current ratio
1.724.731.631.671.59
Interest coverage
10.062.920.331.381.84
Income quality
1.142.420.7-1.033.45
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.170.380.10.840.35
Sales general and administrative to revenue
00000
Research and developement to revenue
0.010.010.020.010.01
Intangibles to total assets
0.160.090.430.430.43
Capex to operating cash flow
-0.25-0.3-0.261.71-0.19
Capex to revenue
-0.05-0.06-0.06-0.06-0.05
Capex to depreciation
-1.16-1.32-0.89-0.92-0.8
Stock based compensation to revenue
0.010.010.0100.01
Graham number
63.6942.5490.931.3448.45
ROIC
0.040.02-0.030.010.02
Return on tangible assets
0.040.010.050.010.02
Graham Net
-41.25-39.67-144.83-144.37-142.66
Working capital
1.86B10.4B2.54B2.6B2.33B
Tangible asset value
3.2B3.36B-5.14B-5.1B-4.98B
Net current asset value
-3.03B-2.85B-13.56B-13.51B-13.31B
Invested capital
0.832.532.672.672.62
Average receivables
1.87B1.72B1.83B2.18B2.14B
Average payables
1.21B1.19B1.32B1.48B1.34B
Average inventory
1.63B1.72B2.27B2.78B2.63B
Days sales outstanding
66.1463.0578.7372.9763.21
Days payables outstanding
63.1757.8569.5658.5353.04
Days of inventory on hand
86.5688.36128.68111.35107.28
Receivables turnover
1.361.431.141.231.42
Payables turnover
1.421.561.291.541.7
Inventory turnover
1.041.020.70.810.84
ROE
0.090.040.140.020.04
Capex per share
-1.14-1.28-1.32-1.51-1.33

CE Frequently Asked Questions

What is Celanese Corporation stock symbol ?

Celanese Corporation is a US stock , located in Irving of Tx and trading under the symbol CE

Is Celanese Corporation buy or a sell ?

19 stock analysts have 19 predictions with a medium analyst target price of $160.05. The lowest prediction is $111 and the highest is $206

What is CE stock prediction ?

With a median analyst target price of $147, 2 stock analysts have made 2 forecasts in last 90 days. $145 is the lowest and $149 is the greatest projection.

What is Celanese Corporation stock quote today ?

Celanese Corporation stock price is $122.01 today.

Is Celanese Corporation stock public?

Yes, Celanese Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap